Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

被引：0
|
作者：
Hiroaki Hagihara
Kazuhiro Nouso
Yoshiyuki Kobayashi
Yoshiaki Iwasaki
Shinichiro Nakamura
Kenji Kuwaki
Junichi Toshimori
Hirokazu Miyatake
Hideki Ohnishi
Hidenori Shiraha
Kazuhide Yamamoto
机构：
[1] Okayama University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Dentistry and Pharmaceutical Sciences,Department of Molecular Hepatology
[3] Okayama University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[4] Dentistry and Pharmaceutical Sciences,undefined
[5] Mitoyo General Hospital,undefined
来源：
International Journal of Clinical Oncology | 2011年 / 16卷
关键词：
Hepatitis C virus; Hepatocellular carcinoma; Recurrence; Survival; PEG-IFN;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：210 / 220
页数：10
相关论文
共 50 条
  • [41] Outcome after resection of hepatitis C virus-related hepatocellular carcinoma improved by postoperative interferon therapy.
    Nishiguchi, S
    Kubo, S
    Hirohashi, K
    Shiomi, S
    Tamori, A
    Oka, H
    Yamazaki, O
    Igawa, S
    Kinoshita, H
    HEPATOLOGY, 2001, 34 (04) : 177A - 177A
  • [42] Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review
    Shu Yang
    Qi Lin
    Wei Lin
    Weilei Hu
    Guosheng Wang
    World Journal of Surgical Oncology, 14
  • [43] Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review
    Yang, Shu
    Lin, Qi
    Lin, Wei
    Hu, Weilei
    Wang, Guosheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [44] Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma
    Harada, Naoki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Morishita, Naoki
    Yamada, Ryoko
    Miyazaki, Masanori
    Yakushijin, Takayuki
    Iio, Sadaharu
    Yamada, Akira
    Ito, Toshifumi
    Hijioka, Taizo
    Inada, Masami
    Katayama, Kazuhiro
    Tamura, Shinji
    Inoue, Atsuo
    Hayashi, Eijirou
    Kato, Michio
    Hikita, Hayato
    Sakamori, Ryotaro
    Miyagi, Takuya
    Tatsumi, Tomohide
    Kanto, Tatsuya
    Kasahara, Akinori
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2013, 58 : 1106A - 1107A
  • [45] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Reply
    Wu, Chun-Ying
    Hsu, Yao-Chun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 766 - 767
  • [46] Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis
    Luo, Jian-Xing
    Zhang, Yang
    Hu, Xiao-Yu
    Xiang, Ne
    HEPATOLOGY INTERNATIONAL, 2024, 18 (1) : 63 - 72
  • [47] Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis
    Jian-Xing Luo
    Yang Zhang
    Xiao-Yu Hu
    Ne Xiang
    Hepatology International, 2024, 18 : 63 - 72
  • [48] Salvage Liver Transplantation for Recurrence after Curative Liver Resection in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Hu, Anbin
    Tai, Qiang
    He, Xiaoshun
    Zhu, Xiaofeng
    LIVER TRANSPLANTATION, 2011, 17 (06) : S157 - S158
  • [49] Direct-acting antiviral therapy reduces the recurrence risk in patients with hepatitis C virus-related early stage hepatocellular carcinoma after curative resection
    Huang, Kuo-Hsuan
    Chen, Chien-Hung
    Hung, Chao-Hung
    Wang, Jing-Houng
    Tsai, Tsung Ming-Chao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 260
  • [50] Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
    Papatheodoridis, GV
    Papadimitropoulos, VC
    Hadziyannis, SJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (05) : 689 - 698
12345